$ITGR

Integer Holdings Corp (ITGR): Entry into a Material Definitive Agreement

Integer Holdings Corp (ITGR) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. On August 2, 2026, Integer Holdings Corporation, a Delaware corporation (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement,” and the transactions contemplated thereby, the “Transaction”), by a

Original reporting
Published Aug 4, 2026, 8:32 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$ITGR
Bullish
medium confidence
Mentioned
$ITGR
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ITGRBullishMed
01

Why it matters

This is a primary M&A disclosure that can shift ITGR’s valuation toward deal economics and increase trading around deal milestones (shareholder vote, regulatory approvals, financing).

02

Market read

The filing is a deal catalyst for ITGR, likely increasing merger-arb and event-driven positioning until key terms and closing conditions are fully digested.

03

What to watch

Traders should focus on merger conditions, any stock exchange delisting provisions, and financing/guarantee mechanics referenced in the agreement, since these often drive spread behavior.

Relevance 6/10Novelty 6/10Timing: filed Aug. 4, 2026 after-hours/late session (8-K filed at 16:32 ET)

Background

The SEC 8-K reports Integer Holdings’ entry into a material definitive agreement and includes an agreement and plan of merger among Integer Holdings Corporation, Armstrong Parent, Inc., and Armstrong Bidco, Inc.

Company-level read

Ticker impact

$ITGRBullishMedium confidence
Context

Integer Holdings filed an 8-K for entry into a material definitive agreement, including an agreement and plan of merger dated Aug. 2, 2026.

Expected impact

Near-term, expect deal-related volatility and potential premium support if the market views the merger terms as credible; downside risk comes from deal-closure conditions and termination provisions.

Evidence & confidence

The article is an SEC 8-K describing entry into a material definitive agreement and attaching an agreement and plan of merger, which is a primary catalyst for M&A pricing. However, the excerpt does not include the consideration amount, structure details, or key conditions, limiting precision on premium and timing.

Market effects

M&A activity can increase attention on healthcare/medical device or related specialty manufacturing deal dynamics, but no sector-wide conclusions are provided in the excerpt.

No specific regional market effects are disclosed beyond the US-listed issuer filing.

No cross-border regulatory or global macro linkage is stated in the provided text.

Counterpoint

A definitive agreement does not guarantee closing; without deal price, financing certainty, and regulatory/termination details, the stock can trade down on perceived execution risk.

Key entities

  • Integer Holdings Corporation

    US-listed issuer filing the 8-K for entry into a material definitive agreement and merger plan.

  • Armstrong Parent, Inc.

    Party to the merger agreement as Parent.

  • Armstrong Bidco, Inc.

    Merger Sub, a wholly owned subsidiary of Parent, party to the merger agreement.

  • KKR Core II Holding Company LLC

    Named in the equity commitment letter referenced as the Sponsor.

Related articles

$ITGRHighAI 9/10

What Integer's Deal Means for Minnesota's Med Device Industry

Integer Holdings, a major medical device manufacturer, is being acquired by KKR for $5.7B. Integer supplies components to companies like Abbott, Boston Scientific, and Medtronic. The deal may impact Minnesota's med-tech industry, where Integer has significant operations. KKR's acquisition could lead to consolidation in the sector, with potential implications for competition and pricing. Integer reported $1.8B in revenue last year.

$KKRHighAI 9/10

KKR to Acquire Integer Holdings in $5.7 Bn All-Cash Deal

KKR will acquire medical device outsourcing company Integer Holdings in an all-cash deal valued at about $5.7 billion, paying $127 per share and assuming Integer’s outstanding debt, according to the companies. The offer implies a 4.78% premium to Integer’s Friday close. Integer shares rose 2.4% premarket. KKR said it will expand its healthcare portfolio.

$SUPNMed

Biotech funding rises 75% year-over-year, Braveheart surges

Macquarie said global biotech funding for the year through Aug. 7 rose 75% YoY, driven by IPOs up 235% and follow-ons up 138%. The XBI biotech index gained 7% in the week to Aug. 7. Braveheart Bio’s upsized IPO raised $382.5M and shares jumped 66%. Curium agreed to buy Lantheus for up to $8B, and Supernus and Indivior plan an all-stock merger.

$KKRHighAI 9/10

KKR to take Integer private for $5.7B

KKR agreed to buy Integer Holdings for about $5.7B in an all-cash deal, taking Integer private. The transaction is expected to close before year-end, subject to regulatory approvals and shareholder support. Integer stockholders would receive about $127 per share, a 51%+ premium to April 29. Integer reported $464M Q2 sales, down 2.6%.